| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galactosemias | 54 | 2024 | 126 | 11.810 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 28 | 2022 | 68 | 4.840 |
Why?
|
| Galactose | 34 | 2022 | 300 | 3.070 |
Why?
|
| Metabolism, Inborn Errors | 12 | 2023 | 292 | 2.250 |
Why?
|
| Inositol | 20 | 2016 | 216 | 1.930 |
Why?
|
| Symporters | 15 | 2016 | 363 | 1.900 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 14 | 2024 | 283 | 1.590 |
Why?
|
| Phosphatidylinositols | 12 | 2016 | 280 | 1.370 |
Why?
|
| Galactokinase | 4 | 2020 | 18 | 1.270 |
Why?
|
| Phenylketonurias | 5 | 2024 | 128 | 1.180 |
Why?
|
| Congenital Disorders of Glycosylation | 6 | 2024 | 50 | 0.980 |
Why?
|
| Ammonia | 11 | 2020 | 247 | 0.930 |
Why?
|
| Maple Syrup Urine Disease | 8 | 2018 | 41 | 0.900 |
Why?
|
| Infertility | 3 | 2023 | 655 | 0.790 |
Why?
|
| UDPglucose 4-Epimerase | 5 | 2022 | 14 | 0.770 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2019 | 1197 | 0.750 |
Why?
|
| Heat-Shock Proteins | 7 | 2003 | 797 | 0.710 |
Why?
|
| Lipid Metabolism, Inborn Errors | 5 | 2023 | 123 | 0.700 |
Why?
|
| Mitochondrial Diseases | 4 | 2018 | 344 | 0.700 |
Why?
|
| Erythrocytes | 13 | 2019 | 2418 | 0.640 |
Why?
|
| Dicarboxylic Acid Transporters | 1 | 2018 | 4 | 0.640 |
Why?
|
| Hyperammonemia | 6 | 2020 | 80 | 0.640 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2018 | 505 | 0.620 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 170 | 0.570 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 301 | 0.560 |
Why?
|
| Succinate-CoA Ligases | 1 | 2016 | 6 | 0.560 |
Why?
|
| Enzyme Assays | 3 | 2019 | 103 | 0.560 |
Why?
|
| Infant, Newborn | 56 | 2023 | 26421 | 0.550 |
Why?
|
| Hypogonadism | 1 | 2023 | 805 | 0.540 |
Why?
|
| Brain Diseases, Metabolic | 3 | 2012 | 44 | 0.510 |
Why?
|
| Hemiplegia | 1 | 2016 | 137 | 0.510 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2017 | 1535 | 0.500 |
Why?
|
| Galactitol | 5 | 2001 | 6 | 0.500 |
Why?
|
| Muscle Hypotonia | 2 | 2016 | 166 | 0.500 |
Why?
|
| Cataract | 2 | 2024 | 837 | 0.490 |
Why?
|
| Neonatal Screening | 7 | 2023 | 619 | 0.490 |
Why?
|
| Chromatography, Liquid | 5 | 2020 | 996 | 0.490 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2020 | 32 | 0.490 |
Why?
|
| Lithium | 3 | 2013 | 600 | 0.480 |
Why?
|
| Alleles | 6 | 2022 | 6894 | 0.470 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2018 | 243 | 0.470 |
Why?
|
| Quadriplegia | 1 | 2016 | 227 | 0.470 |
Why?
|
| Infant | 68 | 2024 | 36535 | 0.470 |
Why?
|
| Apnea | 3 | 2008 | 195 | 0.470 |
Why?
|
| Phenotype | 23 | 2022 | 16726 | 0.470 |
Why?
|
| Oxidation-Reduction | 13 | 2023 | 2227 | 0.460 |
Why?
|
| Alopecia | 1 | 2018 | 416 | 0.460 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2014 | 104 | 0.450 |
Why?
|
| Rhabdomyolysis | 3 | 2020 | 150 | 0.440 |
Why?
|
| Fatty Acids | 9 | 2023 | 1812 | 0.440 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2014 | 142 | 0.430 |
Why?
|
| Carrier Proteins | 8 | 2020 | 4939 | 0.420 |
Why?
|
| Methylmalonyl-CoA Mutase | 3 | 2014 | 23 | 0.410 |
Why?
|
| Uridine Diphosphate Galactose | 10 | 2010 | 21 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2000 | 229 | 0.400 |
Why?
|
| Metabolic Diseases | 6 | 2018 | 684 | 0.400 |
Why?
|
| Homozygote | 10 | 2022 | 1779 | 0.400 |
Why?
|
| Brain | 23 | 2018 | 27362 | 0.400 |
Why?
|
| Humans | 203 | 2024 | 768171 | 0.390 |
Why?
|
| Genotype | 14 | 2022 | 13045 | 0.390 |
Why?
|
| Child, Preschool | 66 | 2024 | 42669 | 0.380 |
Why?
|
| Cryptorchidism | 1 | 2012 | 153 | 0.380 |
Why?
|
| Homocystinuria | 2 | 2010 | 65 | 0.380 |
Why?
|
| Lactation | 1 | 2014 | 392 | 0.380 |
Why?
|
| Nutrition Disorders | 2 | 2008 | 204 | 0.370 |
Why?
|
| Genetic Variation | 4 | 2021 | 6610 | 0.370 |
Why?
|
| Fanconi Syndrome | 2 | 2005 | 35 | 0.370 |
Why?
|
| Uridine Diphosphate Glucose | 8 | 2010 | 22 | 0.370 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2014 | 263 | 0.370 |
Why?
|
| Ovary | 2 | 2023 | 965 | 0.360 |
Why?
|
| Child Development | 2 | 2021 | 2330 | 0.360 |
Why?
|
| Liver Diseases | 2 | 2018 | 1305 | 0.360 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 3 | 2020 | 32 | 0.360 |
Why?
|
| Mutation | 24 | 2021 | 30237 | 0.350 |
Why?
|
| Asbestos, Crocidolite | 2 | 2014 | 18 | 0.350 |
Why?
|
| Urea | 5 | 2020 | 448 | 0.350 |
Why?
|
| Pentose Phosphate Pathway | 2 | 2020 | 126 | 0.350 |
Why?
|
| Child | 78 | 2024 | 80917 | 0.330 |
Why?
|
| Membrane Proteins | 9 | 2012 | 7876 | 0.320 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 979 | 0.320 |
Why?
|
| Dystonia | 1 | 2012 | 378 | 0.310 |
Why?
|
| Marfan Syndrome | 1 | 2010 | 237 | 0.310 |
Why?
|
| Metabolome | 2 | 2014 | 1009 | 0.310 |
Why?
|
| Triglycerides | 4 | 2023 | 2464 | 0.300 |
Why?
|
| Developmental Disabilities | 5 | 2021 | 1518 | 0.300 |
Why?
|
| Reproduction | 1 | 2012 | 646 | 0.300 |
Why?
|
| Glycosylation | 7 | 2024 | 1100 | 0.300 |
Why?
|
| Male | 122 | 2024 | 364731 | 0.300 |
Why?
|
| Brain Chemistry | 4 | 2011 | 958 | 0.290 |
Why?
|
| Female | 116 | 2024 | 397187 | 0.290 |
Why?
|
| DNA Fingerprinting | 1 | 2008 | 114 | 0.290 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1110 | 0.290 |
Why?
|
| Behavior, Animal | 6 | 2016 | 1862 | 0.280 |
Why?
|
| Galactosephosphates | 5 | 2012 | 9 | 0.270 |
Why?
|
| Fertility | 3 | 2023 | 771 | 0.270 |
Why?
|
| Glucose Transporter Type 2 | 2 | 2005 | 61 | 0.270 |
Why?
|
| Nutrition Therapy | 1 | 2008 | 101 | 0.270 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 4 | 2007 | 23 | 0.270 |
Why?
|
| Phenylacetates | 3 | 2017 | 112 | 0.270 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 520 | 0.270 |
Why?
|
| Transaldolase | 2 | 2020 | 10 | 0.260 |
Why?
|
| Adolescent | 56 | 2024 | 89169 | 0.260 |
Why?
|
| Ribosomal Proteins | 1 | 2008 | 369 | 0.260 |
Why?
|
| Glycogen Storage Disease | 2 | 2018 | 41 | 0.250 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 2 | 2004 | 14 | 0.250 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2017 | 3782 | 0.250 |
Why?
|
| Lung Transplantation | 4 | 2000 | 1309 | 0.250 |
Why?
|
| Glutamine | 2 | 2017 | 577 | 0.250 |
Why?
|
| Pleural Neoplasms | 3 | 2014 | 612 | 0.250 |
Why?
|
| Seizures | 7 | 2020 | 2998 | 0.240 |
Why?
|
| Phosphatidylcholines | 1 | 2006 | 406 | 0.240 |
Why?
|
| Mass Spectrometry | 8 | 2020 | 2202 | 0.240 |
Why?
|
| Coenzyme A-Transferases | 2 | 2001 | 7 | 0.240 |
Why?
|
| Coma | 6 | 2017 | 485 | 0.240 |
Why?
|
| Epilepsy | 5 | 2020 | 3326 | 0.240 |
Why?
|
| DNA, Mitochondrial | 5 | 2016 | 872 | 0.240 |
Why?
|
| Cystinuria | 1 | 2024 | 22 | 0.240 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2024 | 28 | 0.240 |
Why?
|
| Amenorrhea | 1 | 2008 | 484 | 0.230 |
Why?
|
| Mesothelioma | 3 | 2014 | 811 | 0.220 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2023 | 8 | 0.220 |
Why?
|
| Fructose Intolerance | 1 | 2023 | 8 | 0.220 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2973 | 0.220 |
Why?
|
| Diabetic Nephropathies | 2 | 2014 | 973 | 0.220 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2003 | 15 | 0.220 |
Why?
|
| Heterozygote | 8 | 2024 | 2798 | 0.220 |
Why?
|
| Mining | 1 | 2004 | 93 | 0.220 |
Why?
|
| Adult | 73 | 2024 | 223646 | 0.220 |
Why?
|
| Peritoneal Neoplasms | 2 | 2014 | 714 | 0.220 |
Why?
|
| Gene Deletion | 4 | 2014 | 2674 | 0.210 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 4978 | 0.210 |
Why?
|
| Lipodystrophy | 1 | 2024 | 145 | 0.210 |
Why?
|
| Phenylalanine | 1 | 2024 | 367 | 0.210 |
Why?
|
| Sudden Infant Death | 2 | 2017 | 293 | 0.200 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2017 | 108 | 0.200 |
Why?
|
| Carnitine | 5 | 2017 | 253 | 0.200 |
Why?
|
| Pyruvic Acid | 1 | 2003 | 205 | 0.200 |
Why?
|
| Enzyme Stability | 2 | 2014 | 219 | 0.200 |
Why?
|
| Heart Arrest | 1 | 2012 | 1515 | 0.200 |
Why?
|
| Breath Tests | 5 | 2004 | 300 | 0.200 |
Why?
|
| Sugar Acids | 2 | 1998 | 24 | 0.200 |
Why?
|
| Bumetanide | 2 | 2013 | 101 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 16044 | 0.190 |
Why?
|
| Point Mutation | 8 | 2020 | 1596 | 0.190 |
Why?
|
| Jaw Abnormalities | 1 | 2021 | 27 | 0.190 |
Why?
|
| Liver | 12 | 2018 | 7578 | 0.190 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2021 | 8 | 0.190 |
Why?
|
| Dihydroorotase | 1 | 2021 | 8 | 0.190 |
Why?
|
| Sodium-Glucose Transporter 1 | 2 | 2014 | 108 | 0.190 |
Why?
|
| Mice | 24 | 2024 | 82049 | 0.190 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2021 | 18 | 0.190 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 2000 | 76 | 0.190 |
Why?
|
| Phosphoric Monoester Hydrolases | 4 | 2016 | 414 | 0.190 |
Why?
|
| Facies | 2 | 2018 | 224 | 0.180 |
Why?
|
| Reflex, Abnormal | 1 | 2021 | 83 | 0.180 |
Why?
|
| Apraxias | 1 | 2021 | 58 | 0.180 |
Why?
|
| Glycerol | 2 | 2019 | 274 | 0.180 |
Why?
|
| Citrulline | 3 | 2001 | 107 | 0.180 |
Why?
|
| Transketolase | 1 | 2020 | 9 | 0.180 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2001 | 46 | 0.180 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2014 | 267 | 0.180 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 3 | 2001 | 17 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 7 | 2016 | 4786 | 0.180 |
Why?
|
| Uridine | 1 | 2021 | 135 | 0.180 |
Why?
|
| Synaptosomes | 5 | 1986 | 116 | 0.180 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 12 | 0.180 |
Why?
|
| Duane Retraction Syndrome | 1 | 2021 | 59 | 0.180 |
Why?
|
| Abnormalities, Multiple | 4 | 2022 | 1424 | 0.180 |
Why?
|
| Arthrogryposis | 1 | 2021 | 69 | 0.180 |
Why?
|
| Fructose | 2 | 2023 | 284 | 0.180 |
Why?
|
| Young Adult | 20 | 2024 | 60066 | 0.180 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 27 | 0.180 |
Why?
|
| Carbon-Nitrogen Ligases | 2 | 2018 | 27 | 0.170 |
Why?
|
| Animals | 43 | 2024 | 169285 | 0.170 |
Why?
|
| Mannosidase Deficiency Diseases | 1 | 2019 | 3 | 0.170 |
Why?
|
| Basal Ganglia | 3 | 2003 | 553 | 0.170 |
Why?
|
| alpha-Mannosidase | 1 | 2019 | 19 | 0.170 |
Why?
|
| Optic Atrophy | 1 | 2020 | 79 | 0.170 |
Why?
|
| Ophthalmoplegia | 1 | 2021 | 168 | 0.170 |
Why?
|
| Death, Sudden | 1 | 2022 | 301 | 0.170 |
Why?
|
| Blepharoptosis | 1 | 2021 | 145 | 0.170 |
Why?
|
| Pregnancy | 8 | 2023 | 30255 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1942 | 0.170 |
Why?
|
| Registries | 4 | 2022 | 8375 | 0.170 |
Why?
|
| Molecular Biology | 1 | 2023 | 573 | 0.170 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2021 | 167 | 0.170 |
Why?
|
| Fatal Outcome | 4 | 2016 | 1836 | 0.170 |
Why?
|
| Craniofacial Abnormalities | 1 | 2022 | 320 | 0.170 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 183 | 0.170 |
Why?
|
| Occupational Exposure | 2 | 2014 | 1807 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2022 | 477 | 0.160 |
Why?
|
| Hypoglycemia | 3 | 2020 | 895 | 0.160 |
Why?
|
| Sodium | 2 | 2003 | 1597 | 0.160 |
Why?
|
| Propionates | 1 | 2000 | 180 | 0.160 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 2016 | 110 | 0.160 |
Why?
|
| Glycerol Kinase | 1 | 2018 | 15 | 0.160 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 2 | 2002 | 59 | 0.160 |
Why?
|
| Glycocalyx | 1 | 2020 | 99 | 0.160 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 1662 | 0.160 |
Why?
|
| Microscopy, Electron | 3 | 2014 | 2560 | 0.160 |
Why?
|
| Hydroxocobalamin | 1 | 2018 | 27 | 0.160 |
Why?
|
| Anemia, Megaloblastic | 1 | 2018 | 24 | 0.160 |
Why?
|
| Arginine | 2 | 2018 | 932 | 0.150 |
Why?
|
| Heart-Lung Transplantation | 1 | 1999 | 87 | 0.150 |
Why?
|
| Genetic Association Studies | 3 | 2020 | 2744 | 0.150 |
Why?
|
| Contracture | 1 | 2021 | 236 | 0.150 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2018 | 14 | 0.150 |
Why?
|
| Fibroblasts | 10 | 2018 | 4178 | 0.150 |
Why?
|
| Glucose | 8 | 2001 | 4352 | 0.150 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2018 | 30 | 0.150 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2018 | 26 | 0.150 |
Why?
|
| Methylmalonic Acid | 3 | 2006 | 51 | 0.150 |
Why?
|
| Neurites | 1 | 2020 | 389 | 0.150 |
Why?
|
| Molecular Sequence Data | 15 | 2013 | 17623 | 0.150 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 335 | 0.150 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2018 | 44 | 0.150 |
Why?
|
| Occupational Diseases | 2 | 2004 | 1457 | 0.150 |
Why?
|
| Cation Transport Proteins | 2 | 2018 | 326 | 0.150 |
Why?
|
| Genes | 4 | 2000 | 1824 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2024 | 873 | 0.150 |
Why?
|
| Carbon Isotopes | 6 | 2004 | 458 | 0.150 |
Why?
|
| Sequence Deletion | 3 | 2016 | 1497 | 0.150 |
Why?
|
| Naphthalenes | 1 | 1998 | 198 | 0.150 |
Why?
|
| Pedigree | 8 | 2021 | 4539 | 0.150 |
Why?
|
| Parenteral Nutrition | 2 | 2014 | 663 | 0.150 |
Why?
|
| Diet, Protein-Restricted | 4 | 2014 | 73 | 0.140 |
Why?
|
| Psychomotor Disorders | 1 | 2018 | 149 | 0.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 2815 | 0.140 |
Why?
|
| Case-Control Studies | 11 | 2024 | 22290 | 0.140 |
Why?
|
| Propionic Acidemia | 1 | 2017 | 9 | 0.140 |
Why?
|
| Lithium Compounds | 2 | 2009 | 226 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 386 | 0.140 |
Why?
|
| Gene Expression | 2 | 2008 | 7601 | 0.140 |
Why?
|
| Asphyxia | 1 | 2017 | 60 | 0.140 |
Why?
|
| Antiporters | 1 | 2018 | 276 | 0.140 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2018 | 124 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 2 | 2015 | 262 | 0.140 |
Why?
|
| Neurons | 3 | 2014 | 9514 | 0.140 |
Why?
|
| Lissencephaly | 1 | 2016 | 36 | 0.140 |
Why?
|
| Liver Transplantation | 3 | 2019 | 2401 | 0.140 |
Why?
|
| Manganese | 2 | 2018 | 394 | 0.130 |
Why?
|
| Adrenal Insufficiency | 1 | 2018 | 195 | 0.130 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 2748 | 0.130 |
Why?
|
| Siblings | 2 | 2021 | 828 | 0.130 |
Why?
|
| Lithium Chloride | 1 | 2016 | 83 | 0.130 |
Why?
|
| Mannosyltransferases | 1 | 2016 | 24 | 0.130 |
Why?
|
| Mice, Knockout | 9 | 2016 | 14488 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 1094 | 0.130 |
Why?
|
| Cardiomyopathies | 3 | 2020 | 2057 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2019 | 549 | 0.130 |
Why?
|
| Oligosaccharides | 1 | 2018 | 407 | 0.130 |
Why?
|
| Potassium Channels | 1 | 2018 | 538 | 0.130 |
Why?
|
| Lipids | 1 | 2006 | 3345 | 0.130 |
Why?
|
| Nerve Endings | 3 | 1986 | 103 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 2 | 2004 | 1605 | 0.120 |
Why?
|
| Middle Aged | 46 | 2024 | 223487 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 646 | 0.120 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2014 | 18 | 0.120 |
Why?
|
| Sarcoma, Kaposi | 1 | 1998 | 376 | 0.120 |
Why?
|
| Parkinsonian Disorders | 1 | 2018 | 285 | 0.120 |
Why?
|
| Base Sequence | 14 | 2012 | 12422 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2020 | 18065 | 0.120 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2014 | 386 | 0.120 |
Why?
|
| Retrospective Studies | 18 | 2024 | 81760 | 0.120 |
Why?
|
| Asbestos, Serpentine | 1 | 2014 | 24 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1998 | 681 | 0.120 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2014 | 14 | 0.120 |
Why?
|
| Physical Endurance | 1 | 2017 | 369 | 0.110 |
Why?
|
| Chelating Agents | 2 | 2018 | 385 | 0.110 |
Why?
|
| Microcephaly | 1 | 2018 | 426 | 0.110 |
Why?
|
| Hepatomegaly | 1 | 2014 | 84 | 0.110 |
Why?
|
| Down Syndrome | 2 | 2000 | 919 | 0.110 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.110 |
Why?
|
| Cheese | 1 | 2014 | 39 | 0.110 |
Why?
|
| Basal Ganglia Diseases | 2 | 1998 | 145 | 0.110 |
Why?
|
| Acrodermatitis | 1 | 1993 | 15 | 0.110 |
Why?
|
| Electroencephalography | 7 | 2020 | 6314 | 0.110 |
Why?
|
| Genetic Counseling | 1 | 2018 | 635 | 0.110 |
Why?
|
| Pancreatitis | 1 | 2001 | 1087 | 0.110 |
Why?
|
| DNA Primers | 6 | 2013 | 2828 | 0.110 |
Why?
|
| Kidney Diseases | 2 | 2014 | 2100 | 0.110 |
Why?
|
| Caseins | 1 | 2014 | 105 | 0.110 |
Why?
|
| Fabaceae | 1 | 2014 | 103 | 0.110 |
Why?
|
| Isoleucine | 1 | 1993 | 111 | 0.110 |
Why?
|
| Tyrosine | 1 | 2018 | 1427 | 0.110 |
Why?
|
| Dystonic Disorders | 1 | 2018 | 354 | 0.110 |
Why?
|
| Telomere | 1 | 2000 | 943 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2018 | 635 | 0.110 |
Why?
|
| Sodium Benzoate | 2 | 2017 | 14 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 1133 | 0.110 |
Why?
|
| Autophagy | 2 | 2018 | 1351 | 0.110 |
Why?
|
| Acute Disease | 4 | 2018 | 7243 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2016 | 414 | 0.100 |
Why?
|
| Lysosomes | 1 | 2018 | 938 | 0.100 |
Why?
|
| Diet Therapy | 1 | 2014 | 150 | 0.100 |
Why?
|
| Tubulin | 1 | 2016 | 695 | 0.100 |
Why?
|
| Neuropsychological Tests | 4 | 2020 | 7140 | 0.100 |
Why?
|
| Hyperargininemia | 1 | 2012 | 12 | 0.100 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 14729 | 0.100 |
Why?
|
| Kidney Glomerulus | 1 | 1995 | 570 | 0.100 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1999 | 828 | 0.100 |
Why?
|
| Uremia | 1 | 2014 | 202 | 0.100 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2012 | 19 | 0.100 |
Why?
|
| Motor Activity | 3 | 2020 | 2711 | 0.100 |
Why?
|
| Dicarboxylic Acids | 1 | 1993 | 75 | 0.100 |
Why?
|
| Phospholipase C beta | 1 | 2012 | 49 | 0.100 |
Why?
|
| Serotonin | 1 | 2017 | 1043 | 0.100 |
Why?
|
| Nutritional Requirements | 1 | 2014 | 279 | 0.100 |
Why?
|
| Amino Acid Sequence | 7 | 2013 | 13422 | 0.100 |
Why?
|
| Phenobarbital | 1 | 2013 | 192 | 0.100 |
Why?
|
| Disease Progression | 5 | 2021 | 13668 | 0.100 |
Why?
|
| Cricetulus | 1 | 2014 | 812 | 0.100 |
Why?
|
| Open Reading Frames | 3 | 2003 | 818 | 0.100 |
Why?
|
| Inhibins | 1 | 2012 | 210 | 0.100 |
Why?
|
| Hexosyltransferases | 1 | 2012 | 58 | 0.100 |
Why?
|
| Polysaccharides | 2 | 2016 | 1024 | 0.100 |
Why?
|
| Sperm Count | 1 | 2012 | 228 | 0.100 |
Why?
|
| Age of Onset | 4 | 2020 | 3346 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 874 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 927 | 0.090 |
Why?
|
| Diarrhea | 1 | 2018 | 1320 | 0.090 |
Why?
|
| Doxorubicin | 1 | 1998 | 2234 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2014 | 498 | 0.090 |
Why?
|
| Inhalation Exposure | 1 | 2014 | 432 | 0.090 |
Why?
|
| Status Epilepticus | 1 | 1997 | 463 | 0.090 |
Why?
|
| CHO Cells | 1 | 2014 | 1379 | 0.090 |
Why?
|
| Twins, Monozygotic | 1 | 2013 | 472 | 0.090 |
Why?
|
| Exons | 5 | 2022 | 2394 | 0.090 |
Why?
|
| Infertility, Female | 1 | 2017 | 763 | 0.090 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 1019 | 0.090 |
Why?
|
| Genome, Human | 3 | 2013 | 4446 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2013 | 447 | 0.090 |
Why?
|
| Choroid Plexus | 1 | 2014 | 249 | 0.090 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 540 | 0.090 |
Why?
|
| Water Pollution | 1 | 2010 | 31 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3670 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 1999 | 1014 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2892 | 0.090 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 293 | 0.090 |
Why?
|
| Antimanic Agents | 2 | 2016 | 524 | 0.090 |
Why?
|
| Environmental Policy | 1 | 2010 | 36 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2179 | 0.090 |
Why?
|
| Pregnancy, Animal | 1 | 2011 | 124 | 0.090 |
Why?
|
| Ataxia Telangiectasia | 2 | 2003 | 107 | 0.090 |
Why?
|
| Mitochondria | 5 | 2014 | 3683 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 806 | 0.090 |
Why?
|
| Cricetinae | 1 | 2014 | 2423 | 0.090 |
Why?
|
| Acidosis | 4 | 2004 | 271 | 0.090 |
Why?
|
| Kinetics | 5 | 2004 | 6330 | 0.090 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 2 | 2000 | 4 | 0.090 |
Why?
|
| International Cooperation | 1 | 2016 | 1436 | 0.090 |
Why?
|
| Aspartic Acid | 3 | 2018 | 577 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 2000 | 4168 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1751 | 0.080 |
Why?
|
| Research Subjects | 1 | 2012 | 249 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 13013 | 0.080 |
Why?
|
| Phlorhizin | 3 | 1994 | 37 | 0.080 |
Why?
|
| Xenopus laevis | 1 | 2014 | 967 | 0.080 |
Why?
|
| Semen | 1 | 2012 | 349 | 0.080 |
Why?
|
| Phenylbutyrates | 2 | 2019 | 72 | 0.080 |
Why?
|
| Hydrolysis | 1 | 2011 | 646 | 0.080 |
Why?
|
| Globus Pallidus | 2 | 2003 | 248 | 0.080 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 498 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2013 | 841 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2474 | 0.080 |
Why?
|
| Genetic Markers | 1 | 1996 | 2603 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 1999 | 1791 | 0.080 |
Why?
|
| Cation Exchange Resins | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cohort Studies | 9 | 2024 | 41753 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2014 | 1688 | 0.080 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2008 | 16 | 0.080 |
Why?
|
| Food | 1 | 2014 | 768 | 0.080 |
Why?
|
| Reproducibility of Results | 6 | 2014 | 20225 | 0.080 |
Why?
|
| Codon, Nonsense | 2 | 2021 | 287 | 0.080 |
Why?
|
| Limit of Detection | 1 | 2010 | 277 | 0.080 |
Why?
|
| Infant Formula | 1 | 2010 | 194 | 0.080 |
Why?
|
| Metabolomics | 2 | 2020 | 1674 | 0.080 |
Why?
|
| Malonates | 1 | 1988 | 43 | 0.080 |
Why?
|
| Oocytes | 1 | 2014 | 1172 | 0.080 |
Why?
|
| Tryptophan | 1 | 2011 | 482 | 0.080 |
Why?
|
| Genetic Testing | 3 | 2020 | 3591 | 0.080 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2018 | 119 | 0.080 |
Why?
|
| Bipolar Disorder | 1 | 2006 | 5130 | 0.080 |
Why?
|
| Cell Line | 7 | 2014 | 15602 | 0.080 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2009 | 293 | 0.080 |
Why?
|
| Leprosy | 1 | 1989 | 125 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2014 | 2048 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2000 | 301 | 0.080 |
Why?
|
| Epilepsies, Partial | 1 | 2012 | 435 | 0.080 |
Why?
|
| Butyryl-CoA Dehydrogenase | 1 | 2007 | 2 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 3728 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2004 | 354 | 0.070 |
Why?
|
| Age Factors | 8 | 2014 | 18415 | 0.070 |
Why?
|
| Atrophy | 4 | 2021 | 1646 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2012 | 434 | 0.070 |
Why?
|
| NADP | 1 | 2008 | 229 | 0.070 |
Why?
|
| Cytosine Nucleotides | 2 | 1986 | 10 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2008 | 727 | 0.070 |
Why?
|
| Cytidine Monophosphate | 2 | 1986 | 11 | 0.070 |
Why?
|
| Infant Nutrition Disorders | 1 | 2008 | 70 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2014 | 810 | 0.070 |
Why?
|
| Founder Effect | 1 | 2007 | 185 | 0.070 |
Why?
|
| Fruit | 1 | 1993 | 1165 | 0.070 |
Why?
|
| Vegetables | 1 | 1993 | 1199 | 0.070 |
Why?
|
| Vertebrates | 1 | 2008 | 227 | 0.070 |
Why?
|
| Dogs | 3 | 1997 | 3845 | 0.070 |
Why?
|
| Asbestos | 2 | 1979 | 251 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3589 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2459 | 0.070 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 1988 | 173 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2012 | 698 | 0.070 |
Why?
|
| Polymorphism, Genetic | 3 | 2017 | 4249 | 0.070 |
Why?
|
| Policy Making | 1 | 2010 | 546 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2016 | 12801 | 0.070 |
Why?
|
| Pediatrics | 1 | 2022 | 3629 | 0.070 |
Why?
|
| Dietary Proteins | 3 | 2001 | 960 | 0.070 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 1986 | 36 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5804 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 5797 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2885 | 0.070 |
Why?
|
| Ketoses | 1 | 2005 | 3 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 2972 | 0.070 |
Why?
|
| Energy Intake | 1 | 2014 | 2146 | 0.070 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 4428 | 0.070 |
Why?
|
| Fetus | 1 | 1993 | 1883 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 1988 | 410 | 0.060 |
Why?
|
| Models, Biological | 1 | 2022 | 9497 | 0.060 |
Why?
|
| Jews | 1 | 2007 | 359 | 0.060 |
Why?
|
| Treatment Outcome | 9 | 2018 | 65379 | 0.060 |
Why?
|
| Thrombosis | 1 | 2020 | 2957 | 0.060 |
Why?
|
| Zebrafish | 1 | 2017 | 3035 | 0.060 |
Why?
|
| BCG Vaccine | 1 | 1989 | 381 | 0.060 |
Why?
|
| Myocardium | 2 | 1998 | 4790 | 0.060 |
Why?
|
| Disease Management | 4 | 2018 | 2535 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenase | 2 | 2003 | 57 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2010 | 812 | 0.060 |
Why?
|
| Australia | 6 | 2014 | 1265 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2020 | 10099 | 0.060 |
Why?
|
| Critical Care | 1 | 2018 | 2715 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1676 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2004 | 1772 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 3 | 2000 | 1205 | 0.060 |
Why?
|
| Reference Standards | 1 | 2009 | 1014 | 0.060 |
Why?
|
| Tremor | 1 | 2006 | 197 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1758 | 0.060 |
Why?
|
| Heart | 1 | 1998 | 4446 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2020 | 6684 | 0.060 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2024 | 35 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 2 | 2022 | 842 | 0.060 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2024 | 40 | 0.060 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2024 | 42 | 0.060 |
Why?
|
| NAD | 1 | 2008 | 618 | 0.060 |
Why?
|
| Kidney | 6 | 2014 | 7064 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2012 | 2202 | 0.060 |
Why?
|
| Western Australia | 1 | 2004 | 41 | 0.060 |
Why?
|
| Leukocytes | 4 | 2018 | 2034 | 0.060 |
Why?
|
| Cystine | 1 | 2024 | 96 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 22380 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4712 | 0.060 |
Why?
|
| Citrate (si)-Synthase | 1 | 2004 | 48 | 0.060 |
Why?
|
| Textile Industry | 1 | 2004 | 74 | 0.060 |
Why?
|
| Tissue Extracts | 1 | 2004 | 139 | 0.060 |
Why?
|
| Cystinosis | 1 | 2004 | 26 | 0.060 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2018 | 474 | 0.060 |
Why?
|
| Sorbitol | 1 | 2023 | 61 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 7454 | 0.050 |
Why?
|
| Dietary Carbohydrates | 4 | 2012 | 896 | 0.050 |
Why?
|
| DNA Mutational Analysis | 4 | 2005 | 4120 | 0.050 |
Why?
|
| Progesterone | 1 | 2008 | 752 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2003 | 32 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2003 | 30 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3447 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2003 | 44 | 0.050 |
Why?
|
| Hydroxybutyrates | 1 | 2003 | 76 | 0.050 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2003 | 88 | 0.050 |
Why?
|
| Electron Transport | 1 | 2004 | 211 | 0.050 |
Why?
|
| Infusion Pumps | 1 | 2004 | 163 | 0.050 |
Why?
|
| Lactates | 1 | 2004 | 401 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 26379 | 0.050 |
Why?
|
| Sucrose | 1 | 2023 | 157 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 39354 | 0.050 |
Why?
|
| Mortality | 2 | 2004 | 2911 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2001 | 1648 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2018 | 1194 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18349 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2012 | 1605 | 0.050 |
Why?
|
| Phentolamine | 1 | 1982 | 102 | 0.050 |
Why?
|
| Biliary Atresia | 1 | 2002 | 88 | 0.050 |
Why?
|
| Aged | 19 | 2024 | 171502 | 0.050 |
Why?
|
| Asbestosis | 2 | 1979 | 81 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 9561 | 0.050 |
Why?
|
| Allergens | 2 | 2000 | 1443 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 1 | 1988 | 1485 | 0.050 |
Why?
|
| Leucine | 2 | 2001 | 547 | 0.050 |
Why?
|
| Ketone Bodies | 1 | 2001 | 76 | 0.050 |
Why?
|
| Frameshift Mutation | 2 | 2020 | 392 | 0.050 |
Why?
|
| Autopsy | 2 | 2017 | 1011 | 0.050 |
Why?
|
| Testosterone | 1 | 2012 | 2491 | 0.050 |
Why?
|
| Diet | 4 | 2014 | 8089 | 0.050 |
Why?
|
| Syndrome | 4 | 2013 | 3273 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1379 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 7073 | 0.050 |
Why?
|
| Hypertension, Portal | 1 | 2004 | 230 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 1999 | 657 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2000 | 2521 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2496 | 0.050 |
Why?
|
| Hematoma, Subdural | 3 | 1986 | 128 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2004 | 591 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3463 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 8080 | 0.050 |
Why?
|
| Estrogens | 1 | 2008 | 1536 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 550 | 0.050 |
Why?
|
| Ligases | 2 | 1995 | 333 | 0.040 |
Why?
|
| Amylases | 1 | 2001 | 171 | 0.040 |
Why?
|
| Phylogeny | 1 | 2008 | 2843 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2001 | 6082 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2001 | 775 | 0.040 |
Why?
|
| Cattle | 3 | 1996 | 3819 | 0.040 |
Why?
|
| Enteral Nutrition | 2 | 2001 | 802 | 0.040 |
Why?
|
| Time Factors | 7 | 2014 | 40220 | 0.040 |
Why?
|
| Rats | 9 | 2013 | 23782 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2008 | 1812 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 437 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2000 | 15833 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2003 | 1266 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase | 2 | 1997 | 25 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 1 | 2000 | 175 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2006 | 1426 | 0.040 |
Why?
|
| Electromyography | 2 | 2003 | 1401 | 0.040 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 3706 | 0.040 |
Why?
|
| Diet, Vegetarian | 1 | 2001 | 181 | 0.040 |
Why?
|
| RNA, Transfer, Leu | 1 | 1999 | 13 | 0.040 |
Why?
|
| Cross Infection | 1 | 1988 | 1425 | 0.040 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 2018 | 29 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 1999 | 39 | 0.040 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 12795 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 1999 | 50 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2000 | 304 | 0.040 |
Why?
|
| Cerebellum | 2 | 2003 | 1522 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2006 | 785 | 0.040 |
Why?
|
| Reference Values | 6 | 2011 | 4939 | 0.040 |
Why?
|
| Cerebellar Diseases | 1 | 2021 | 227 | 0.040 |
Why?
|
| Cells, Cultured | 6 | 2018 | 19025 | 0.040 |
Why?
|
| Lipase | 1 | 2001 | 321 | 0.040 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2018 | 26 | 0.040 |
Why?
|
| Prevalence | 4 | 2024 | 15869 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 2001 | 291 | 0.040 |
Why?
|
| Glycine | 2 | 1995 | 672 | 0.040 |
Why?
|
| Folate Receptor 1 | 1 | 2018 | 41 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2004 | 916 | 0.040 |
Why?
|
| Anticonvulsants | 3 | 2013 | 1923 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 307 | 0.040 |
Why?
|
| Growth | 2 | 1992 | 366 | 0.040 |
Why?
|
| New Zealand | 1 | 1999 | 360 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1525 | 0.040 |
Why?
|
| Tetrahydrofolates | 1 | 2018 | 58 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2001 | 325 | 0.040 |
Why?
|
| Emergency Medicine | 2 | 2018 | 1223 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2003 | 1179 | 0.040 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 1997 | 40 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2005 | 2614 | 0.040 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2017 | 94 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2018 | 139 | 0.040 |
Why?
|
| Biopsy | 3 | 2004 | 6792 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2004 | 1129 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2018 | 239 | 0.040 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1997 | 100 | 0.040 |
Why?
|
| Sleep | 1 | 2013 | 4818 | 0.040 |
Why?
|
| Th1 Cells | 2 | 2000 | 1042 | 0.040 |
Why?
|
| China | 2 | 1999 | 2395 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 556 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1676 | 0.030 |
Why?
|
| Th2 Cells | 2 | 2000 | 1078 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2001 | 749 | 0.030 |
Why?
|
| Anisotropy | 1 | 2020 | 1292 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2230 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 1996 | 121 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2000 | 1989 | 0.030 |
Why?
|
| Plasma | 1 | 2020 | 585 | 0.030 |
Why?
|
| Brain Stem | 2 | 2017 | 859 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 435 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36741 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2020 | 772 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2018 | 526 | 0.030 |
Why?
|
| Hematoma, Epidural, Cranial | 2 | 1986 | 59 | 0.030 |
Why?
|
| Lactose | 1 | 1996 | 95 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 243 | 0.030 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1996 | 81 | 0.030 |
Why?
|
| Vitamin B 12 | 2 | 2014 | 529 | 0.030 |
Why?
|
| Cystathionine beta-Synthase | 1 | 1995 | 27 | 0.030 |
Why?
|
| Glutamates | 1 | 2017 | 385 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 224 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2004 | 6340 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2017 | 326 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 1169 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13677 | 0.030 |
Why?
|
| Carbon-Carbon Ligases | 1 | 1995 | 19 | 0.030 |
Why?
|
| Pyridoxine | 1 | 1995 | 108 | 0.030 |
Why?
|
| North America | 1 | 1999 | 1289 | 0.030 |
Why?
|
| MELAS Syndrome | 1 | 1995 | 55 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 3056 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 9617 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 9540 | 0.030 |
Why?
|
| Edema | 1 | 1999 | 765 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 2 | 2014 | 2227 | 0.030 |
Why?
|
| Intelligence | 2 | 1991 | 926 | 0.030 |
Why?
|
| Phloretin | 1 | 1994 | 16 | 0.030 |
Why?
|
| Liposomes | 1 | 1998 | 792 | 0.030 |
Why?
|
| Genes, myb | 1 | 2013 | 18 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1998 | 7609 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 1769 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 1997 | 402 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 1995 | 160 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2014 | 82 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 1998 | 413 | 0.030 |
Why?
|
| Peptide Elongation Factors | 1 | 2013 | 60 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1994 | 323 | 0.030 |
Why?
|
| Drug Carriers | 1 | 1998 | 710 | 0.030 |
Why?
|
| Hippocampus | 1 | 2006 | 3783 | 0.030 |
Why?
|
| Craniocerebral Trauma | 3 | 1986 | 493 | 0.030 |
Why?
|
| Biological Transport | 2 | 1998 | 2085 | 0.030 |
Why?
|
| Nephritis | 1 | 2014 | 147 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4206 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 222 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2923 | 0.030 |
Why?
|
| Infant Food | 1 | 1993 | 139 | 0.030 |
Why?
|
| Risk Factors | 6 | 2017 | 74944 | 0.030 |
Why?
|
| Lung | 3 | 2003 | 10101 | 0.030 |
Why?
|
| Age Distribution | 1 | 1999 | 2873 | 0.030 |
Why?
|
| Carnitine Acyltransferases | 1 | 1992 | 8 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2003 | 3447 | 0.030 |
Why?
|
| Amino Acids | 1 | 1999 | 1716 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 3956 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 369 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11095 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 2862 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 1563 | 0.030 |
Why?
|
| Prognosis | 9 | 2018 | 30009 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15949 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 370 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23648 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2006 | 4492 | 0.030 |
Why?
|
| Bacteriophages | 1 | 1996 | 382 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2013 | 110 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2016 | 696 | 0.020 |
Why?
|
| Prone Position | 1 | 2013 | 203 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2024 | 54924 | 0.020 |
Why?
|
| Nephritis, Interstitial | 1 | 2013 | 158 | 0.020 |
Why?
|
| Italy | 1 | 2014 | 856 | 0.020 |
Why?
|
| Ubiquinone | 1 | 2013 | 183 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2006 | 3301 | 0.020 |
Why?
|
| Europe | 1 | 1999 | 3436 | 0.020 |
Why?
|
| Incidence | 5 | 2017 | 21538 | 0.020 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6229 | 0.020 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2013 | 158 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1998 | 1367 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2003 | 3573 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1998 | 710 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 716 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2018 | 1309 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 687 | 0.020 |
Why?
|
| Culture Media | 1 | 1993 | 898 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 394 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2909 | 0.020 |
Why?
|
| Albuminuria | 1 | 1995 | 658 | 0.020 |
Why?
|
| Blood Glucose | 3 | 2001 | 6431 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 20762 | 0.020 |
Why?
|
| Glucosyltransferases | 1 | 1991 | 94 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 2087 | 0.020 |
Why?
|
| Acetonitriles | 1 | 2011 | 55 | 0.020 |
Why?
|
| Water Pollutants | 1 | 2010 | 25 | 0.020 |
Why?
|
| Echocardiography | 1 | 2004 | 5047 | 0.020 |
Why?
|
| Fetal Hemoglobin | 1 | 2013 | 346 | 0.020 |
Why?
|
| Blood | 1 | 1993 | 599 | 0.020 |
Why?
|
| Hospital Bed Capacity | 2 | 1988 | 202 | 0.020 |
Why?
|
| Language | 1 | 2020 | 1557 | 0.020 |
Why?
|
| Transferrin | 1 | 2012 | 283 | 0.020 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 136 | 0.020 |
Why?
|
| Fresh Water | 1 | 2010 | 83 | 0.020 |
Why?
|
| Cell Division | 2 | 1999 | 4477 | 0.020 |
Why?
|
| Electron Transport Complex IV | 3 | 1997 | 189 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2094 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 753 | 0.020 |
Why?
|
| Leigh Disease | 1 | 1991 | 89 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 367 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 794 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 380 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 1998 | 1032 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 2013 | 364 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 1993 | 552 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 5505 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 6124 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 1798 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1995 | 1968 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2003 | 6283 | 0.020 |
Why?
|
| Stem Cells | 1 | 2003 | 3538 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1999 | 1554 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2008 | 13053 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 1016 | 0.020 |
Why?
|
| Hospitalization | 3 | 2012 | 10840 | 0.020 |
Why?
|
| Phosphotransferases | 2 | 1991 | 302 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12252 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 2204 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2011 | 394 | 0.020 |
Why?
|
| Carbon Radioisotopes | 2 | 2001 | 567 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 948 | 0.020 |
Why?
|
| Dehydration | 1 | 1991 | 216 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1991 | 434 | 0.020 |
Why?
|
| Water Supply | 1 | 2010 | 204 | 0.020 |
Why?
|
| Papua New Guinea | 1 | 1989 | 47 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 1839 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2012 | 334 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 1264 | 0.020 |
Why?
|
| Energy Metabolism | 2 | 1998 | 2907 | 0.020 |
Why?
|
| Binding Sites | 1 | 1997 | 6019 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14783 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3814 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1760 | 0.020 |
Why?
|
| Phospholipids | 2 | 1983 | 787 | 0.020 |
Why?
|
| Isovaleryl-CoA Dehydrogenase | 1 | 1988 | 5 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8542 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2010 | 194 | 0.020 |
Why?
|
| Creatine | 2 | 2003 | 427 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3140 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2008 | 64 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2017 | 824 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 937 | 0.020 |
Why?
|
| Hormones | 1 | 2012 | 866 | 0.020 |
Why?
|
| Chromatography, Gas | 2 | 2000 | 150 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2013 | 733 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2014 | 1429 | 0.020 |
Why?
|
| Biodiversity | 1 | 2010 | 345 | 0.020 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2007 | 5 | 0.020 |
Why?
|
| Ovalbumin | 2 | 2000 | 677 | 0.020 |
Why?
|
| Citrullinemia | 1 | 2007 | 3 | 0.020 |
Why?
|
| Biotin | 1 | 1989 | 256 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1991 | 931 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1680 | 0.020 |
Why?
|
| Autistic Disorder | 2 | 2010 | 1240 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 2683 | 0.020 |
Why?
|
| Anthropometry | 1 | 2012 | 1346 | 0.020 |
Why?
|
| Swimming | 1 | 2008 | 209 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2001 | 9384 | 0.020 |
Why?
|
| Insulin | 1 | 2001 | 6610 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2013 | 1058 | 0.020 |
Why?
|
| CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase | 1 | 1986 | 3 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3620 | 0.020 |
Why?
|
| Choline | 2 | 1999 | 522 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 4620 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1999 | 9669 | 0.020 |
Why?
|
| Internationality | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Carbon Dioxide | 2 | 2001 | 1148 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 201 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2001 | 3729 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5028 | 0.020 |
Why?
|
| Aorta | 1 | 1993 | 2045 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3806 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 1758 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1998 | 2334 | 0.020 |
Why?
|
| Trachea | 1 | 1991 | 1095 | 0.020 |
Why?
|
| Georgia | 1 | 2005 | 186 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1995 | 325 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 997 | 0.020 |
Why?
|
| Hip Joint | 1 | 2012 | 1018 | 0.020 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2010 | 598 | 0.020 |
Why?
|
| Mosaicism | 1 | 1988 | 480 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 1904 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1998 | 6004 | 0.020 |
Why?
|
| Skull Fractures | 4 | 1986 | 203 | 0.010 |
Why?
|
| Fixation, Ocular | 4 | 1986 | 243 | 0.010 |
Why?
|
| Mitochondria, Muscle | 2 | 1999 | 172 | 0.010 |
Why?
|
| Cysteamine | 1 | 2004 | 24 | 0.010 |
Why?
|
| Social Behavior | 1 | 2011 | 1147 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 2395 | 0.010 |
Why?
|
| Protons | 2 | 2001 | 1113 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4861 | 0.010 |
Why?
|
| Epidemiologic Methods | 2 | 1979 | 1328 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15453 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 1385 | 0.010 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2003 | 5 | 0.010 |
Why?
|
| Ketone Oxidoreductases | 1 | 2003 | 5 | 0.010 |
Why?
|
| Nucleotides | 1 | 1986 | 455 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2011 | 1434 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1983 | 89 | 0.010 |
Why?
|
| Kupffer Cells | 1 | 2004 | 143 | 0.010 |
Why?
|
| Peptides | 1 | 1995 | 4354 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2007 | 553 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2003 | 79 | 0.010 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2002 | 22 | 0.010 |
Why?
|
| Spinal Injuries | 1 | 1986 | 300 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6316 | 0.010 |
Why?
|
| Cause of Death | 1 | 2013 | 3721 | 0.010 |
Why?
|
| Sex Factors | 3 | 2012 | 10632 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2003 | 261 | 0.010 |
Why?
|
| Quality of Life | 2 | 2017 | 13490 | 0.010 |
Why?
|
| Inflammation | 2 | 2000 | 10873 | 0.010 |
Why?
|
| Mass Screening | 1 | 1998 | 5458 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10590 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1998 | 4363 | 0.010 |
Why?
|
| Language Disorders | 1 | 2003 | 140 | 0.010 |
Why?
|
| Body Composition | 1 | 1992 | 2462 | 0.010 |
Why?
|
| Research | 1 | 2010 | 1979 | 0.010 |
Why?
|
| Calcium | 2 | 2012 | 5792 | 0.010 |
Why?
|
| Health Surveys | 2 | 1988 | 4057 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8142 | 0.010 |
Why?
|
| Succinate-Semialdehyde Dehydrogenase | 1 | 2003 | 96 | 0.010 |
Why?
|
| Animals, Suckling | 1 | 2001 | 69 | 0.010 |
Why?
|
| Infection Control | 1 | 1988 | 984 | 0.010 |
Why?
|
| United States | 3 | 2020 | 73039 | 0.010 |
Why?
|
| Psychometrics | 1 | 2011 | 3063 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9374 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2018 | 24318 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2000 | 6231 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2003 | 625 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 11930 | 0.010 |
Why?
|
| Weight Loss | 1 | 1992 | 2721 | 0.010 |
Why?
|
| Physicians | 1 | 2018 | 4598 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2000 | 455 | 0.010 |
Why?
|
| Skin | 1 | 1994 | 4505 | 0.010 |
Why?
|
| Phosphates | 1 | 1983 | 765 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 411 | 0.010 |
Why?
|
| Markov Chains | 1 | 2003 | 979 | 0.010 |
Why?
|
| Cerebral Cortex | 2 | 2003 | 5812 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8509 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1892 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 2122 | 0.010 |
Why?
|
| Asthma | 1 | 1999 | 6291 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 664 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1999 | 100 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1981 | 629 | 0.010 |
Why?
|
| Food, Formulated | 1 | 1980 | 103 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 1988 | 1546 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1999 | 125 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3445 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 897 | 0.010 |
Why?
|
| Bone Density | 1 | 2012 | 3573 | 0.010 |
Why?
|
| Patient Admission | 4 | 1986 | 1365 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 1854 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1998 | 82 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1999 | 220 | 0.010 |
Why?
|
| Muscles | 2 | 1995 | 1582 | 0.010 |
Why?
|
| London | 1 | 1979 | 233 | 0.010 |
Why?
|
| Spinal Cord Injuries | 1 | 1986 | 928 | 0.010 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1998 | 64 | 0.010 |
Why?
|
| Vitamin D | 1 | 2012 | 3311 | 0.010 |
Why?
|
| RNA, Transfer, Lys | 1 | 1997 | 8 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 2 | 2003 | 5536 | 0.010 |
Why?
|
| Creatinine | 1 | 2004 | 1918 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1999 | 766 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6512 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3980 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2003 | 1140 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 965 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 699 | 0.010 |
Why?
|
| Hypertension | 1 | 1998 | 8616 | 0.010 |
Why?
|
| England | 1 | 1979 | 533 | 0.010 |
Why?
|
| Cathepsin A | 1 | 1996 | 4 | 0.010 |
Why?
|
| Aging | 2 | 1994 | 8743 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 1998 | 98 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 14164 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2003 | 1741 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 1141 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2357 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2001 | 1105 | 0.010 |
Why?
|
| Retinal Vein Occlusion | 1 | 1998 | 149 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 1156 | 0.010 |
Why?
|
| Pulse | 2 | 1986 | 218 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5107 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1627 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 1219 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1995 | 52 | 0.010 |
Why?
|
| Glycosuria | 1 | 1995 | 44 | 0.010 |
Why?
|
| Biotinidase | 1 | 1995 | 17 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1743 | 0.010 |
Why?
|
| Food, Fortified | 1 | 1996 | 189 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1995 | 148 | 0.010 |
Why?
|
| Nitrogen | 1 | 1996 | 345 | 0.010 |
Why?
|
| Aneurysm | 1 | 1998 | 343 | 0.010 |
Why?
|
| Brain Injuries | 1 | 1986 | 2057 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1524 | 0.010 |
Why?
|
| Shock | 2 | 1986 | 316 | 0.010 |
Why?
|
| Eosinophils | 1 | 1999 | 952 | 0.010 |
Why?
|
| Hemiterpenes | 1 | 1993 | 18 | 0.010 |
Why?
|
| Pentanoic Acids | 1 | 1993 | 19 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1999 | 2627 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 1993 | 56 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3772 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 1993 | 49 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2486 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 8052 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2001 | 2592 | 0.010 |
Why?
|
| Membranes | 1 | 1992 | 164 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2002 | 1960 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 6986 | 0.010 |
Why?
|
| DNA | 2 | 2000 | 7213 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2000 | 3161 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1992 | 411 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1998 | 864 | 0.010 |
Why?
|
| Carbachol | 1 | 1991 | 223 | 0.010 |
Why?
|
| Trichloroacetic Acid | 1 | 1991 | 48 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2010 | 6983 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2000 | 2323 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 1998 | 59626 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1979 | 957 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1998 | 1320 | 0.010 |
Why?
|
| Calmodulin | 1 | 1991 | 241 | 0.010 |
Why?
|
| Phosphorus | 1 | 1992 | 336 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3403 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5756 | 0.010 |
Why?
|
| Blood Preservation | 1 | 1991 | 169 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5402 | 0.010 |
Why?
|
| Cephalometry | 1 | 1992 | 380 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1991 | 504 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1992 | 389 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1999 | 1172 | 0.010 |
Why?
|
| Obesity | 1 | 1992 | 13091 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1998 | 3655 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 548 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 4262 | 0.000 |
Why?
|
| Twins, Dizygotic | 1 | 1989 | 236 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1995 | 4034 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1305 | 0.000 |
Why?
|
| Muscle Contraction | 1 | 1991 | 1209 | 0.000 |
Why?
|
| Diuretics, Osmotic | 1 | 1986 | 32 | 0.000 |
Why?
|
| Nutritional Status | 1 | 1995 | 1628 | 0.000 |
Why?
|
| Ambulances | 1 | 1986 | 94 | 0.000 |
Why?
|
| Rabbits | 1 | 1991 | 4773 | 0.000 |
Why?
|
| Accidents | 1 | 1986 | 164 | 0.000 |
Why?
|
| Transportation of Patients | 1 | 1986 | 177 | 0.000 |
Why?
|
| Diagnosis-Related Groups | 1 | 1986 | 445 | 0.000 |
Why?
|
| Hospitals, Rural | 1 | 1986 | 174 | 0.000 |
Why?
|
| Cytokines | 1 | 1999 | 7452 | 0.000 |
Why?
|
| Thoracic Injuries | 1 | 1986 | 288 | 0.000 |
Why?
|
| Survival Rate | 1 | 1996 | 12840 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1996 | 12543 | 0.000 |
Why?
|
| Smoking | 1 | 1979 | 9092 | 0.000 |
Why?
|
| Hospitals, Teaching | 1 | 1986 | 1157 | 0.000 |
Why?
|
| Probability | 1 | 1986 | 2479 | 0.000 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 818 | 0.000 |
Why?
|
| Consciousness | 1 | 1986 | 602 | 0.000 |
Why?
|
| Blood Pressure | 2 | 1986 | 8543 | 0.000 |
Why?
|
| Hypotension | 1 | 1986 | 888 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1992 | 3334 | 0.000 |
Why?
|
| Citrates | 1 | 1980 | 134 | 0.000 |
Why?
|
| Transcription Factors | 1 | 1998 | 12171 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1979 | 13586 | 0.000 |
Why?
|
| Neoplasms | 1 | 1979 | 22371 | 0.000 |
Why?
|
| Emergency Service, Hospital | 1 | 1986 | 7951 | 0.000 |
Why?
|